Table 5.

Complications of VTE prophylaxis during hospitalization

Questions	Medical Directors	Membership	Total	P- value
Do you modify the VTE prophylaxis protocol when concerned about bleeding risk?
No	36 (31.9%)	44 (35.5%)	80 (33.8%)	.556
Yes	77 (68.1%)	80 (64.5%)	157 (66.2%)
In your practice, have you seen any patients who received extended chemoprophylaxis and developed PE?
No	92 (82.1%)	99 (79.2%)	191 (80.6%)	.557
Yes	20 (17.9%)	26 (20.8%)	46 (19.4%)
Which postoperative complications would keep you from using extended chemoprophylaxis?*
Infection	2 (1%)	0 (0%)	2 (.5%)	.222
Return to operating room	8 (4.2%)	5 (2.6%)	13 (3.4%)	.228
Any bleeding	23 (12%)	26 (13.5%)	49 (12.8%)	.955
Bleeding requiring chemoprophylaxis cessation and observation	53 (27.6%)	48 (25%)	101 (26.3%)	.141
Bleeding requiring chemoprophylaxis cessation and blood transfusion	48 (25%)	48 (25%)	96 (25%)	.464
Bleeding requiring chemoprophylaxis cessation and reoperation	41 (21.4%)	46 (24%)	87 (22.7%)	.968
Other	1 (.5%)	0 (0%)	1 (.3%)	.470
None	16 (8.3%)	19 (9.9%)	35 (9.1%)	.837
In your practice, did your patients have any side effects from extended VTE chemoprophylaxis?*
Hematoma	36 (22.5%)	36 (21.2%)	72 (21.8%)	.625
Infection	1 (.6%)	0 (0%)	1 (.3%)	.478
Bleeding requiring chemoprophylaxis cessation and observation	31 (19.4%)	32 (18.8%)	63 (19.1%)	.794
Bleeding requiring chemoprophylaxis cessation and blood transfusion	22 (13.8%)	22 (13%)	44 (13.3%)	.746
Bleeding requiring chemoprophylaxis cessation and reoperation	12 (7.5%)	11 (6.5%)	23 (7%)	.658
Other	5 (3.1%)	2 (1.2%)	7 (2.1%)	.263
None	53 (33.1%)	67 (39.4%)	120 (36.4%)	.246

VTE = venous thromboembolism; PE = pulmonary embolism.

Data are expressed as n (%).

P value is calculated using Chi-square or Fisher’s exact test when appropriate.

^*Multiple response questions.